trending Market Intelligence /marketintelligence/en/news-insights/trending/z3d5tmlni7zjgvd6gvqsjg2 content esgSubNav
In This List

Tyme Technologies appoints director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Tyme Technologies appoints director

Tyme Technologies Inc.'s board appointed Don DeGolyer as a class I independent director.

DeGolyer is the founder, CEO and a director of Vertice Pharma LLC, a specialty pharmaceuticals company focused on improving patients' health.

New York-based Tyme Technologies is a clinical-stage pharmaceutical company, which focuses on the discovery and development of cancer therapeutics for various oncology indications.